# In Loving Memory of Alice J Harrison – Clinical Commentary > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/clinical-commentary-cannabis-medicine-insights/ > **Published:** 2026-04-03T00:04:44-04:00 | **Last Modified / Clinically Audited:** 2026-09-29T00:11:06-04:00 > **Clinical Summary:** Explore clinical commentary cannabis medicine focusing on evidence, ethics, and data quality in emerging cannabis research and policy developments. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Clinical EvidenceMedical EthicsData Quality Clinical Summary The provided link appears to reference an obituary notice rather than [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) or medical findings related to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). No medical data, treatment outcomes, or clinical evidence is available for analysis from this source. Clinical Perspective 🧠 For meaningful clinical insights, healthcare providers and patients should focus on peer-reviewed research, [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/), and documented case studies rather than memorial notices. [Evidence-based medicine](https://cedclinic.com/digital-health-expertise-modern-challenge/) requires verifiable clinical data to inform practice decisions. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20In%20Loving%20Memory%20of%20Alice%20J%20Harrison%20-%20The%20Facts%20Newspaper%20%40drcaplan&url=https%3A//www.thefactsnewspaper.com/post/in-loving-memory-of-alice-j-harrison)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.thefactsnewspaper.com/post/in-loving-memory-of-alice-j-harrison)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20In%20Loving%20Memory%20of%20Alice%20J%20Harrison%20-%20The%20Facts%20Newspaper%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.thefactsnewspaper.com/post/in-loving-memory-of-alice-j-harrison)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.thefactsnewspaper.com/post/in-loving-memory-of-alice-j-harrison](https://www.thefactsnewspaper.com/post/in-loving-memory-of-alice-j-harrison) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system) - [What type of medical content does this article cover?](#What_type_of_medical_content_does_this_article_cover) - [What does “Notable Clinical Interest” mean for healthcare providers?](#What_does_8220Notable_Clinical_Interest8221_mean_for_healthcare_providers) - [What are the main topic areas addressed in this cannabis medical article?](#What_are_the_main_topic_areas_addressed_in_this_cannabis_medical_article) - [How should healthcare providers interpret this type of clinical news?](#How_should_healthcare_providers_interpret_this_type_of_clinical_news) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to be a rating scale that categorizes medical findings and developments by their clinical importance. This particular article received a rating of #70, indicating “Notable Clinical Interest” for emerging findings worth monitoring closely. #### What type of medical content does this article cover? This article focuses on cannabis-related medical news from CED Clinic. It covers topics related to clinical evidence, medical ethics, and data quality in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). #### What does “Notable Clinical Interest” mean for healthcare providers? Notable Clinical Interest indicates that the findings or policy developments are emerging and worth monitoring closely by medical professionals. While not necessarily requiring immediate action, these developments may influence future clinical practice. #### What are the main topic areas addressed in this cannabis medical article? The article addresses three key areas: clinical evidence regarding cannabis treatments, medical ethics considerations in cannabis medicine, and data quality issues in [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/). These represent critical aspects of evidence-based cannabis therapeutics. #### How should healthcare providers interpret this type of clinical news? Healthcare providers should view this as developing information that warrants attention but may not yet be ready for immediate clinical implementation. The focus on clinical evidence, ethics, and data quality suggests ongoing research and policy evolution in cannabis medicine. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “In Loving Memory of Alice J Harrison – The Facts Newspaper”, “url”: “https://www.thefactsnewspaper.com/post/in-loving-memory-of-alice-j-harrison”, “datePublished”: “2026-04-02T21:25:06Z”, “about”: “loving memory alice j harrison facts”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Cannabis Briefs for April 7, 2026 – Shanken News Daily Stay updated with the latest cannabis news and clinical developments from April 2026. A concise summary for healthcare professionals and researchers. Read Cannabis Briefs [Cannabis Research](https://cedclinic.com/pediatric-cannabis-certification-care-children/): A Pathway to Better Health Explore how cannabis research extends beyond science to impact health outcomes and policy. Essential reading for clinicians and patients alike. Explore Cannabis Research [News & Commentary: April 5, 2026 OnLabor](https://cedclinic.com/clinical-commentary-cannabis-evidence-april-5-2026/) Insights and commentary on recent cannabis clinical news and policy updates relevant to medical professionals and stakeholders. [View News & Commentary](https://cedclinic.com/clinical-commentary-cannabis-evidence-april-5-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).